Therapeutic targeting of immunometabolism in Alzheimer's disease reveals a critical reliance on Hexokinase 2 dosage on microglial activation and disease progression.
Saved in:
| Title: | Therapeutic targeting of immunometabolism in Alzheimer's disease reveals a critical reliance on Hexokinase 2 dosage on microglial activation and disease progression. |
|---|---|
| Authors: | Codocedo JF; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Mera-Reina C; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Lin PB; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Puntambekar SS; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Casali BT; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Jury N; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Martinez P; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Lasagna-Reeves CA; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA., Landreth GE; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2023 Nov 15. Date of Electronic Publication: 2023 Nov 15. |
| Publication Type: | Preprint; Journal Article |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38014106 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Therapeutic targeting of immunometabolism in Alzheimer's disease reveals a critical reliance on Hexokinase 2 dosage on microglial activation and disease progression. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Codocedo+JF%22">Codocedo JF</searchLink>; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA.<br /><searchLink fieldCode="AU" term="%22Mera-Reina+C%22">Mera-Reina C</searchLink>; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA.<br /><searchLink fieldCode="AU" term="%22Lin+PB%22">Lin PB</searchLink>; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA.<br /><searchLink fieldCode="AU" term="%22Puntambekar+SS%22">Puntambekar SS</searchLink>; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA.<br /><searchLink fieldCode="AU" term="%22Casali+BT%22">Casali BT</searchLink>; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA.<br /><searchLink fieldCode="AU" term="%22Jury+N%22">Jury N</searchLink>; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA.<br /><searchLink fieldCode="AU" term="%22Martinez+P%22">Martinez P</searchLink>; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA.<br /><searchLink fieldCode="AU" term="%22Lasagna-Reeves+CA%22">Lasagna-Reeves CA</searchLink>; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA.<br /><searchLink fieldCode="AU" term="%22Landreth+GE%22">Landreth GE</searchLink>; Stark Neurosciences Research Institute, Indiana University, School of Medicine, Indianapolis, IN 46202, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101680187%22">BioRxiv : the preprint server for biology</searchLink> [bioRxiv] 2023 Nov 15. <i>Date of Electronic Publication: </i>2023 Nov 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Preprint; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101680187 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2692-8205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226928205%22">26928205 </searchLink><i>NLM ISO Abbreviation: </i>bioRxiv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38014106 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1101/2023.11.11.566270 Languages: – Code: eng Text: English Titles: – TitleFull: Therapeutic targeting of immunometabolism in Alzheimer's disease reveals a critical reliance on Hexokinase 2 dosage on microglial activation and disease progression. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Codocedo JF – PersonEntity: Name: NameFull: Mera-Reina C – PersonEntity: Name: NameFull: Lin PB – PersonEntity: Name: NameFull: Puntambekar SS – PersonEntity: Name: NameFull: Casali BT – PersonEntity: Name: NameFull: Jury N – PersonEntity: Name: NameFull: Martinez P – PersonEntity: Name: NameFull: Lasagna-Reeves CA – PersonEntity: Name: NameFull: Landreth GE IsPartOfRelationships: – BibEntity: Dates: – D: 15 M: 11 Text: 2023 Nov 15 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2692-8205 Titles: – TitleFull: BioRxiv : the preprint server for biology Type: main |
| ResultId | 1 |
